Pro Share Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$9.23 - $22.43 $88,737 - $215,642	-9,614 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$14.86 - $23.55 $37,239 - $59,016	-2,506 Reduced 20.68%	9,614 $200,000
Q4 2021 Feb 08, 2022	BUY	$19.99 - $30.24 $242,278 - $366,508	12,120 New	12,120 $280,000
Q3 2021 Nov 12, 2021	SELL	$26.84 - $36.58 $182,619 - $248,890	-6,804 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$28.01 - $36.01 $190,580 - $245,012	6,804 New	6,804 $232,000

43.2M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $63.4M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.